Can Mounjaro Cause Breakouts or Skin Changes?

Is acne officially listed as a Mounjaro side effect?

The short answer is no. The Mounjaro SmPC, published on the electronic Medicines Compendium, does not include acne or facial breakouts in its adverse reaction tables. The recognised skin-related effects are injection-site reactions (localised redness, bruising, swelling or itching at the spot where you inject) which tend to resolve within a day or two and are reduced by rotating sites correctly.

Allergic skin reactions are also listed as something to watch for: a widespread rash, hives or urticaria can indicate hypersensitivity. These are different in character from an ordinary spot and typically come on relatively quickly after a dose. If you develop a rash that spreads or is accompanied by swelling around the face or throat, that is a reason to seek medical attention the same day, not to wait for your next review.

The NHS medicines page for tirzepatide outlines the common and serious effects in plain language and is a reliable first port of call if you want to cross-check a symptom against the official list.

Why might your skin break out while you're taking Mounjaro?

Several mechanisms can produce spots during tirzepatide treatment, none of them a direct pharmacological effect of the medicine itself. First, rapid weight loss tends to alter circulating androgen and oestrogen levels — particularly as body fat decreases, because fat tissue produces oestrogens. That hormonal shift can tip the balance of sebum production and provoke breakouts, much as hormonal fluctuations do at other life stages.

Second, the medicine significantly reduces appetite and changes what many people eat. If your diet shifts abruptly (less fibre, different macro ratios, fewer vegetables) your gut microbiome adjusts too, and emerging evidence links gut-skin communication to acne. Staying well hydrated matters here; Mounjaro can cause nausea and reduced fluid intake, and mild dehydration shows up on skin quickly.

Third, some people change their supplement or skincare routines at the same time as starting treatment, making it genuinely difficult to isolate the cause. Timing coincidences are common. Starting Mounjaro and noticing spots two weeks later does not establish that tirzepatide caused them.

A fuller picture of what tirzepatide can and cannot cause is covered on our overview of Mounjaro's reported effects, which rounds up the evidence across common queries.

Could breakouts be related to dose changes or hormonal shifts?

Possibly. Tirzepatide is titrated upward over months, starting at 2.5 mg and moving through 5, 7.5, 10, 12.5 and 15 mg doses as tolerated. Each step-up can briefly revive GI side effects as the body adjusts, and some patients notice other symptoms around those transitions too.

Hormone levels tend to continue shifting as weight loss accumulates, so someone who had clear skin at 5 mg might notice a brief flare around the move to 10 mg, not because the dose is causing acne directly but because weight loss is accelerating and bringing hormonal changes with it. Women on oral contraceptives should also know that tirzepatide can affect how the pill is absorbed, the NHS recommends adding a non-oral method for the first four weeks of treatment and for four weeks after each dose increase. A change in contraceptive absorption could conceivably affect hormonal balance enough to influence skin.

If you are finding the dose-change periods difficult for any reason, it is worth knowing that taking a short break from Mounjaro is something prescribers can discuss with you, though changes to your treatment schedule should always be agreed clinically rather than self-managed.

When should a skin change on Mounjaro prompt you to contact someone?

Most mild breakouts do not need urgent action, they can be managed with consistent skincare and usually settle as the body adjusts over the first few months of treatment. That said, a few specific presentations should not be left until your next routine review.

Contact a clinician promptly if you notice: a rash that appears suddenly after a dose and spreads beyond the injection site; hives, welts or raised itchy plaques anywhere on the body; swelling of the face, lips or tongue alongside a skin reaction; or any skin change accompanied by breathing difficulty. These may indicate a hypersensitivity reaction and need same-day assessment.

Similarly, if a spot or cluster of spots becomes very painful, swells significantly or shows signs of infection (warmth, discharge, significant redness spreading outward) that is a GP conversation rather than a wait-and-see.

For anything less urgent, your prescriber at a regulated online pharmacy is there to answer questions between doses. Skin changes are also something that could come up during the clinical re-review that happens before every repeat order at nume's consultation, a good moment to raise it if you're not sure whether what you're seeing is worth mentioning.

You can read about how tirzepatide works as a dual GIP and GLP-1 receptor agonist on our tirzepatide overview, or see the full treatment context on the Mounjaro page. If you're curious about one specific symptom that's been worrying you, there are also pages exploring questions like breast tenderness on Mounjaro for a sense of how these investigative questions tend to unfold. If you are considering a branded alternative, you can find out more about Empower tirzepatide and how it compares as part of that wider research. Any suspected side effect can be reported directly via the MHRA Yellow Card scheme, which also accepts reports from patients, not only clinicians.